| Gene symbol | GPC3 | Synonyms | DGSX, GTR2-2, MXR7, OCI-5, SDYS, SGB, SGBS, SGBS1 | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq26.2 | dbXrefs | |
| Description | glypican 3 | ||||
| GTO ID | GTC2831 |
| Trial ID | NCT05103631 |
| Disease | Solid Tumor | Embryonal Sarcoma | Liposarcoma | Yolk Sac Tumor | Malignant Rhabdoid Tumor | Liver Carcinoma | Rhabdomyosarcoma |
| Altered gene | GPC3 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CATCH T cells |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Hepatocellular Carcinoma |
| Year | 2021 |
| Country | United States |
| Company sponsor | Baylor College of Medicine |
| Other ID(s) | H-49796 CATCH |
| Vector information | |||||||
|
|||||||
| Cohort 1 | |||||||||||
|
|||||||||||